CBP501: Completed Phase II enrollment

CanBas completed enrollment of 63 chemotherapy-naïve patients in an open-label, international Phase II trial comparing IV CBP501 plus cisplatin and pemetrexed vs. pemetrexed and cisplatin alone. Eli ...